Urinary trypsin inhibitor suppresses migration of malignant mesothelioma

Cancer Letters

Volumn 288, Issue 2, 2010, Pages 214-218

  Yaguchi, Takahiro ^a   Muramoto, Masakazu ^a   Nakano, Takashi ^a   Nishizaki, Tomoyuki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Malignant mesothelioma; Migration; Platelet derived growth factor receptor; Platelet derived growth factor D; Urinary trypsin inhibitor

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR D; ULINASTATIN;

ARTICLE; CANCER CELL; CELL MIGRATION; CELL STIMULATION; CELL TYPE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; MALIGNANT MESOTHELIOMA; MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; CHEMOTAXIS; GLYCOPROTEINS; HUMANS; LYMPHOKINES; MESOTHELIOMA; NEOPLASM INVASIVENESS; PLATELET-DERIVED GROWTH FACTOR; PROTEIN MULTIMERIZATION; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TIME FACTORS;

BOVINAE;

EID: 74849135702     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.07.003     Document Type: Article

References (13)

1. Ustach C.V., and Kim H.R. Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells. Mol. Cell. Biol. 25 (2005) 6279-6288
2. Filiberti R., Marroni P., Neri M., Ardizzoni A., Betta P.G., Cafferata M.A., Canessa P.A., Puntoni R., Ivaldi G.P., and Paganuzzi M. Serum PDGF-AB in pleural mesothelioma. Tumour Biol. 26 (2005) 221-226
3. Metheny-Barlow L.J., Flynn B., van Gijssel H.E., Marrogi A., and Gerwin B.I. Paradoxical effects of platelet-derived growth factor - a overexpression in malignant mesothelioma. Antiproliferative effects in vitro and tumorigenic stimulation in vivo. Am. J. Respir. Cell Mol. Biol. 24 (2001) 694-702
4. Klominek J., Baskin B., and Hauzenberger D. Platelet-derived growth factor (PDGF) BB acts as a chemoattractant for human malignant mesothelioma cells via PDGF receptor β-integrin α3β1 interaction. Clin. Exp. Metastas. 16 (1998) 529-539
5. Zhong J., Gencay M.M., Bubendorf L., Burgess J.K., Parson H., Robinson B.W., Tamm M., Black J.L., and Roth M. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells. J. Cell. Physiol. 207 (2006) 540-552
6. Kobayashi H. Suppression of urokinase expression and tumor metastasis by bikunin overexpression. Hum. Cell. 14 (2001) 233-236
7. Kobayashi H., Gotoh J., Kanayama N., Hirashima Y., Terao T., and Sugino D. Inhibition of tumor cell invasion through matrigel by a peptide derived from the domain II region in urinary trypsin inhibition. Cancer Res. 55 (1995) 1847-1852
8. Kobayashi H., Shinohara H., Gotoh J., Fujie M., Fujishiro S., and Terao T. Anti-metastatic therapy by urinary trypsin inhibitor in combination with an anti-cancer agent. Br. J. Cancer 72 (1995) 1131-1137
9. Kobayashi H., Shinohara H., Takeuchi K., Itoh M., Fujie M., Saitoh M., and Terao T. Inhibition of the soluble and the tumor cell receptor-bound plasmin by urinary trypsin inhibitor and subsequent effects on tumor cell invasion and metastasis. Cancer Res. 54 (1994) 844-849
10. Kobayashi H., Suzuki M., Sun G.W., Hirashima Y., and Terao T. Suppression of urokinase-type plasminogen activator expression from human ovarian cancer cells by urinary trypsin inhibitor. Biochim. Biophys. Acta 1481 (2000) 310-316
11. Yoshioka I., Tsuchiya Y., Aozuka Y., Onishi Y., Sakurai H., Koizumi K., Tsukada K., and Saiki I. Urinary trypsin inhibitor suppresses surgical stress-facilitated lung metastasis of murine colon 26-L5 carcinoma cells. Anticancer Res. 25 (2005) 815-820
12. Ricono J.M., Wagner B., Gorin Y.C., Arar M., Kazlauskas A., Ghosh Choudjury G., and Abboud H.E. PDGF receptor β modulates metanephric mesenchyme chemotaxis induced by PDGF AA. Am. J. Physiol. Renal Physiol. (2008) (Epub ahead of print)
13. Hobson J.P., Rosenfeldt H.M., Barak L.S., Olivera A., Poulton S., Caron M.G., Milstien S., and Spiegel S. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science 291 (2001) 1800-1803